Published in Brain Res Brain Res Rev on January 27, 1993
Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med (2015) 4.57
Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology (2010) 2.74
Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med (2009) 2.41
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults. JAMA Neurol (2016) 1.76
The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm (Vienna) (2006) 1.50
Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol (2005) 1.48
Review of pharmacological treatment in mood disorders and future directions for drug development. Neuropsychopharmacology (2011) 1.28
Leveraging the cortical cholinergic system to enhance attention. Neuropharmacology (2012) 0.96
α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics. Br J Clin Pharmacol (2011) 0.93
Probing peripheral and central cholinergic system responses. J Psychiatry Neurosci (2000) 0.86
Separate and combined effects of scopolamine and nicotine on retrieval-induced forgetting. Psychopharmacology (Berl) (2003) 0.84
Dose-specific effects of scopolamine on canine cognition: impairment of visuospatial memory, but not visuospatial discrimination. Psychopharmacology (Berl) (2004) 0.84
Protective effects of mangosteen extract on H2O2-induced cytotoxicity in SK-N-SH cells and scopolamine-induced memory impairment in mice. PLoS One (2013) 0.81
Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects. Br J Clin Pharmacol (2011) 0.81
Ameliorating Effects of Ethanol Extract of Fructus mume on Scopolamine-Induced Memory Impairment in Mice. Evid Based Complement Alternat Med (2015) 0.80
Therapeutic approaches to age-associated neurocognitive disorders. Dialogues Clin Neurosci (2001) 0.79
Genetic and pharmacological approaches to evaluate the interaction between the cannabinoid and cholinergic systems in cognitive processes. Br J Pharmacol (2007) 0.79
Safety and short-term outcomes of endoscopic submucosal dissection for early gastric cancer in elderly patients. Endosc Int Open (2016) 0.78
Human models as tools in the development of psychotropic drugs. Dialogues Clin Neurosci (2002) 0.78
Dose effects of triazolam and scopolamine on metamemory. Exp Clin Psychopharmacol (2010) 0.78
Pharmacological models in Alzheimer's disease research. Dialogues Clin Neurosci (2000) 0.77
Task- and Treatment Length-Dependent Effects of Vortioxetine on Scopolamine-Induced Cognitive Dysfunction and Hippocampal Extracellular Acetylcholine in Rats. J Pharmacol Exp Ther (2016) 0.75
Characterization of bladder selectivity of antimuscarinic agents on the basis of in vivo drug-receptor binding. Int Neurourol J (2012) 0.75
Postoperative Delirium in Elderly Patients Undergoing Hip Fracture Surgery in the Sugammadex Era: A Retrospective Study. Biomed Res Int (2016) 0.75
Anticholinergic medication use and dementia: latest evidence and clinical implications. Ther Adv Drug Saf (2016) 0.75
Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjects. Br J Clin Pharmacol (2016) 0.75
Over-Prescribed Medications, Under-Appreciated Risks: A Review of the Cognitive Effects of Anticholinergic Medications in Older Adults. Mo Med (2016) 0.75
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry (2001) 7.30
Amino acid sequence of the human fibronectin receptor. J Cell Biol (1987) 4.08
A primary genetic map of chromosome 13q. Am J Hum Genet (1986) 4.01
Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry (2001) 3.87
Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. Lancet (1989) 3.69
Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med (1993) 3.62
DNA-based immunization by in vivo transfection of dendritic cells. Nat Med (1996) 3.62
Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther (2001) 3.59
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem (1986) 2.95
Cognitive effects of corticosteroids. Am J Psychiatry (1990) 2.85
Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc (1989) 2.83
ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry (2001) 2.74
Rectal and pharyngeal gonorrhea in homosexual men. JAMA (1972) 2.73
Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci U S A (1993) 2.44
Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study. J Abnorm Child Psychol (2000) 2.36
Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron (2001) 2.29
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr (2001) 2.20
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
Surface differentiation antigens of human mammary epithelial cells carried on the human milk fat globule. Proc Natl Acad Sci U S A (1977) 2.16
Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat Med (1995) 2.06
The response of two contrasting limestone grasslands to simulated climate change. Science (2000) 2.06
Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry (2001) 1.98
Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry (2000) 1.90
Nurses could halve GP workload. BMJ (1995) 1.81
Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol (2000) 1.76
Symptom profiles in children with ADHD: effects of comorbidity and gender. J Am Acad Child Adolesc Psychiatry (2001) 1.76
Reports of extraordinary fecundity in early California. Bull N Y Acad Med (1973) 1.74
Appearance and distribution of surface proteins of the human erythrocyte membrane. An electron microscope and immunochemical labeling study. J Cell Biol (1978) 1.73
Effect of acute coronary artery occlusion on local myocardial extracellular K+ activity in swine. Circulation (1980) 1.69
How do patients with Alzheimer's disease cope with their illness? A clinical experience report. J Am Geriatr Soc (1995) 1.68
Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone. Am J Psychiatry (2000) 1.64
Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry (2001) 1.63
Biodiversity in urban habitat patches. Sci Total Environ (2005) 1.58
Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry (1996) 1.58
Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res (2004) 1.57
Late-onset SCA2: 33 CAG repeats are sufficient to cause disease. Neurology (2000) 1.56
Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science (1996) 1.56
No consistent effect of plant diversity on productivity. Science (2000) 1.52
Durable power of attorney and informed consent with Alzheimer's disease patients: a clinical study. Am J Psychiatry (1997) 1.50
Specificity of memory impairments with triazolam use. Lancet (1991) 1.47
Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. Arch Gen Psychiatry (1990) 1.46
Estrogen replacement therapy and outcome of coronary balloon angioplasty in postmenopausal women. Am J Cardiol (1998) 1.44
The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography. Arch Neurol (1991) 1.44
A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP. Biol Psychiatry (1993) 1.44
A double FDG/PET study of the effects of scopolamine in older adults. Neuropsychopharmacology (1994) 1.44
Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology (2001) 1.43
Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis. J Clin Psychiatry (1990) 1.41
A functional anatomical study of associative learning in humans. Proc Natl Acad Sci U S A (1994) 1.40
Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. Biochemistry (1999) 1.40
Aging and mental health: primary care of the healthy older adult. A roundtable discussion: Part I. Geriatrics (1992) 1.37
Genetic influence of the kidneys on blood pressure. Evidence from chronic renal homografts in rats with opposite predispositions to hypertension. Circ Res (1974) 1.37
Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Curr Pharm Des (2010) 1.37
Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum (2008) 1.34
Familial aggregation of ADHD characteristics. J Abnorm Child Psychol (2000) 1.32
Posttraumatic stress disorder and service utilization among urban mental health center clients. J Trauma Stress (1999) 1.31
A high-resolution radiation hybrid map of the human genome draft sequence. Science (2001) 1.30
Multiple representations contribute to body knowledge processing. Evidence from a case of autotopagnosia. Brain (1991) 1.30
Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. Child Adolesc Psychiatr Clin N Am (2000) 1.29
Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). J Abnorm Child Psychol (2000) 1.28
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2009) 1.27
Endemic contamination of clinical specimens by Mycobacterium gordonae. Clin Infect Dis (2000) 1.27
Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry (2001) 1.25
Genetics and visual attention: selective deficits in healthy adult carriers of the epsilon 4 allele of the apolipoprotein E gene. Proc Natl Acad Sci U S A (2000) 1.22
Interaction of acidosis and increased extracellular potassium on action potential characteristics and conduction in guinea pig ventricular muscle. Circ Res (1982) 1.22
A randomized trial of magnesium in the emergency department treatment of children with asthma. Ann Emerg Med (2000) 1.22
Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice. J Am Acad Child Adolesc Psychiatry (1999) 1.17
The flat-top gene is required for the expansion and regionalization of the telencephalic primordium. Development (1999) 1.17
Estrogen blocks early T cell development in the thymus. Am J Reprod Immunol (1996) 1.17
Plasmid labeling confirms bacterial translocation in pancreatitis. Am J Surg (1994) 1.14
Immunologic methods for the identification of cell types. I. Specific antibodies that distinguish between mammary gland epithelial cells and fibroblasts. J Natl Cancer Inst (1976) 1.14
Studies on the antigenic properties of egg-white lysozyme. I. Isolation and characterization of a tryptic peptide from reduced and alkylated lysozyme exhibiting haptenic activity. Biochemistry (1968) 1.12
Rheumatoid factors isolated from patients with autoimmune disorders are derived from germline genes distinct from those encoding the Wa, Po, and Bla cross-reactive idiotypes. J Clin Invest (1991) 1.12
Development of an experimental animal model for reactive arthritis induced by Yersinia enterocolitica infection. Infect Immun (1987) 1.12
Study of Reiter's syndrome, with special emphasis on Yersinia enterocolitica. Immunol Rev (1985) 1.11
Behavioural and temperamental characteristics of children and adolescents suffering from primary headache. Cephalalgia (2006) 1.11
Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells. Oncogene (2010) 1.11
Comparative evaluation of a commercial enzyme immunoassay for the detection of human antibody to Rickettsia typhi. Clin Diagn Lab Immunol (1995) 1.11
Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study. Arch Gen Psychiatry (1987) 1.10
Race as a risk factor in cadaver kidney transplantation. Arch Surg (1979) 1.10
Initial experience with transvaginal incisional hernia repair. Hernia (2009) 1.09
Survival in cats with naturally occurring chronic kidney disease (2000-2002). J Vet Intern Med (2008) 1.08
Medication management of stimulants in pediatric practice settings: a national perspective. J Dev Behav Pediatr (2000) 1.07
Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology. J Autism Dev Disord (2000) 1.06
Effectiveness of a dot-blot immunoassay of anti-Rickettsia tsutsugamushi antibodies for serologic analysis of scrub typhus. Am J Trop Med Hyg (1995) 1.06
c-Src differentially regulates the functions of microtentacles and invadopodia. Oncogene (2010) 1.05
Identification of regions of the P2X(7) receptor that contribute to human and rat species differences in antagonist effects. Br J Pharmacol (2008) 1.05
The activation of porcine pancreatic phospholipase A2 by dipalmitoylphosphatidylcholine large unilamellar vesicles. Analysis of the state of aggregation of the activated enzyme. J Biol Chem (1987) 1.05
Working memory and apolipoprotein E: what's the connection? Neuropsychologia (2002) 1.05
Dementia of the Alzheimer type: clinical and family study of 22 twin pairs. Neurology (1987) 1.04
A qualitative investigation of perceptions of violence risk factors in low-income African American children. J Clin Child Psychol (2001) 1.04
Nucleotide sequence analysis of rheumatoid factors and polyreactive antibodies derived from patients with rheumatoid arthritis reveals diverse use of VH and VL gene segments and extensive variability in CDR-3. Scand J Immunol (1992) 1.04
Separation of the high affinity insulin-like growth factor I receptor from low affinity binding sites by affinity chromatography. J Biol Chem (1987) 1.04
Rat pup ultrasonic isolation calls: possible mediation by the benzodiazepine receptor complex. Pharmacol Biochem Behav (1986) 1.04
Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate. J Infect Dis (2000) 1.04
Characteristics of pediatric firearm fatalities. J Pediatr Surg (1990) 1.03
Immunogenic and antigenic epitopes of immunoglobulins binding of human monoclonal anti-D antibodies to FcRI on the monocyte-like U937 cell line. Vox Sang (1988) 1.02
IgA and IgM rheumatoid factors as markers of later erosive changes in rheumatoid arthritis (RA). Scand J Rheumatol Suppl (1988) 1.02